Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors

Clinical trial NCT07570745 · RECRUITING

Trial details

NCT number: NCT07570745
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Graft-Versus-Host Disease(GVHD)Bone Marrow Transplantation

Start date: 2026-05-01
Primary completion: 2028-05-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.